if the largest pharmacy chains like CVS, walmart, costco and possibly others dont report the weekly scripts numbers, WHY everybody is looking for these numbers which dont mean much. i would rather read the comments of the real afrezza users in the real world. if the resulta are so good, you have to consider what the doctors will do when these results become available to them and when the patients will demand for afrezza. since it is approved by FDA, the doctors will have no choice but to listen to their patients, otherwise they will lose them. it is a big battle for the patinets with private insurances between doctors in all specialities. the family practitioners cannot prescribe chemotherapy, therefore the cancer patients have no choice but to continue to see their oncologists. ehen it comes to diabetes many patients are treated by their primary physicians and dont need endocrinologists. think about how afrezza will do once the internists will be visited by the sanofi reps. also many internists have spirometers and will buy them if needed. the endocrinologists are afraid to get involved in measuring FEV 1 , therefore they will delay using Afrezza because they will need to reffer patients for spirometry to other physicians.
everybody knows that doctors treat hundred of diseases with drugs. most of the drugs are chemicals which are treating the effects of the diseases. antibiotics are killing the microorganisms, parkinson medications do not bring back to live the lost neurons from the substantia nigra in the brain. high blood pressure medications use different mechanisms to lower the blood pressure. the closest medications to treat the causes of diseases are the replacement hormones like thyroid hormones, cortisol for addison etc. in the case of diabetes we want to have an ultrashort insulin which works like a real pancreas and a decrease in the insulin resistance(the metabolic syndrome) . the results of the Afrezza users seem to suggest that this drug is the closest diabetic treatment to real life. the Hb A1 C is decreasing considerably, the insulin resistance is lowered, patients are losing weight and with time the so many diabetes complications have to decrease. these are the reasons why i invested in MNKD. real results from real life and not from FDA designed studies.
i agree that this could be a possibility. i have a fidelity account and in order to receive interest to lend my share for shorting they sent me a bunch of papers to sign from bank of america and jp morgan as far as i remember. there was some fine print and some risk that i was taking so i decided not to sign the papers .